Page last updated: 2024-08-23

pravastatin and Vascular Diseases

pravastatin has been researched along with Vascular Diseases in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (10.00)	18.2507
2000's	6 (60.00)	29.6817
2010's	3 (30.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lingsma, HF; Mooijaart, SP; Nieboer, D; Steyerberg, EW; Trompet, S; van Leeuwen, N	1
Bezlyak, V; Buckley, BM; de Craen, AJ; Ford, I; Jukema, JW; Packard, CJ; Perry, I; Sattar, N; Shepherd, J; Stott, DJ; Westendorp, RG	1
Hata, M; Hirayama, A; Minami, K; Sezai, A; Takayama, T; Yoshitake, I	1
Bollen, EL; de Craen, AJ; Jukema, JW; Kremer, D; Pons, D; Slagboom, PE; Trompet, S; Westendorp, RG	1
Buckley, BM; de Craen, AJ; Ford, I; Jukema, JW; Postmus, I; Sattar, N; Slagboom, PE; Stott, DJ; Trompet, S; Westendorp, RG	1
Traut, V	1
Anderson, E; Dinnett, EM; Gaw, A; Kent, JA; McIntyre, KE; Mungall, MM; Ronald, ES	1
Dinnett, EM; Gaw, A; Kent, JA; Mungall, MM; Ronald, ES	1
Dong, YF; Kataoka, K; Kim-Mitsuyama, S; Lai, ZF; Matsuba, S; Ogawa, H; Tanaka, T; Tokutomi, Y; Yamamoto, E; Yamashita, T	1
Kamata, K; Kasuya, Y; Suenaga, H; Sugiura, M	1

Trials

2 trial(s) available for pravastatin and Vascular Diseases

Article	Year
Variation in the CBP gene involved in epigenetic control associates with cognitive function. Neurobiology of aging, 2011, Volume: 32, Issue:3 Topics: Aged; Aged, 80 and over; Cognition; CREB-Binding Protein; Epigenomics; Female; Gene Frequency; Genotype; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Linear Models; Longitudinal Studies; Male; Neuropsychological Tests; Polymorphism, Single Nucleotide; Pravastatin; Vascular Diseases	2011
Unblinding of trial participants to their treatment allocation: lessons from the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER). Clinical trials (London, England), 2005, Volume: 2, Issue:3 Topics: Aged; Anticholesteremic Agents; Attitude to Health; Cholesterol; Disclosure; Double-Blind Method; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Patient Rights; Patient Selection; Physicians, Family; Placebos; Pravastatin; Prospective Studies; Randomized Controlled Trials as Topic; Research Design; Risk Factors; Vascular Diseases	2005

Article

Year

Variation in the CBP gene involved in epigenetic control associates with cognitive function.

Neurobiology of aging, 2011, Volume: 32, Issue:3

Topics: Aged; Aged, 80 and over; Cognition; CREB-Binding Protein; Epigenomics; Female; Gene Frequency; Genotype; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Linear Models; Longitudinal Studies; Male; Neuropsychological Tests; Polymorphism, Single Nucleotide; Pravastatin; Vascular Diseases

2011

Unblinding of trial participants to their treatment allocation: lessons from the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER).

Clinical trials (London, England), 2005, Volume: 2, Issue:3

Topics: Aged; Anticholesteremic Agents; Attitude to Health; Cholesterol; Disclosure; Double-Blind Method; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Patient Rights; Patient Selection; Physicians, Family; Placebos; Pravastatin; Prospective Studies; Randomized Controlled Trials as Topic; Research Design; Risk Factors; Vascular Diseases

2005

Other Studies

8 other study(ies) available for pravastatin and Vascular Diseases

Article	Year
Regression discontinuity was a valid design for dichotomous outcomes in three randomized trials. Journal of clinical epidemiology, 2018, Volume: 98 Topics: Adrenal Cortex Hormones; Adult; Aged; Anticholesteremic Agents; Causality; Confidence Intervals; Coronary Occlusion; Craniocerebral Trauma; Fibrinolytic Agents; Humans; Logistic Models; Middle Aged; Odds Ratio; Pravastatin; Randomized Controlled Trials as Topic; Regression Analysis; Reproducibility of Results; Streptokinase; Tissue Plasminogen Activator; Treatment Outcome; Vascular Diseases; Young Adult	2018
Reduced glomerular filtration rate and its association with clinical outcome in older patients at risk of vascular events: secondary analysis. PLoS medicine, 2009, Jan-20, Volume: 6, Issue:1 Topics: Aged; Aged, 80 and over; Cardiovascular Diseases; Female; Glomerular Filtration Rate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Diseases; Male; Pravastatin; Prospective Studies; Risk Factors; Treatment Outcome; Vascular Diseases	2009
Efficacy of aggressive lipid controlling therapy for preventing saphenous vein graft disease. The Annals of thoracic surgery, 2009, Volume: 88, Issue:5 Topics: Anticholesteremic Agents; Coronary Artery Bypass; Female; Fluorobenzenes; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Male; Middle Aged; Pravastatin; Pyrimidines; Radiography; Rosuvastatin Calcium; Saphenous Vein; Sulfonamides; Ultrasonography; Vascular Diseases	2009
PCSK9 SNP rs11591147 is associated with low cholesterol levels but not with cognitive performance or noncardiovascular clinical events in an elderly population. Journal of lipid research, 2013, Volume: 54, Issue:2 Topics: Activities of Daily Living; Aged; Cholesterol, LDL; Cognition; Female; Follow-Up Studies; Humans; Male; Polymorphism, Single Nucleotide; Pravastatin; Proprotein Convertase 9; Proprotein Convertases; Serine Endopeptidases; Vascular Diseases	2013
[The Prosper-Study: practical consequences?]. Der Internist, 2004, Volume: 45, Issue:5 Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Female; Humans; Hypercholesterolemia; Male; Pravastatin; Risk Assessment; Risk Factors; Treatment Outcome; Vascular Diseases	2004
Closing out a large clinical trial: lessons from the prospective study of pravastatin in the elderly at risk (PROSPER). Clinical trials (London, England), 2004, Volume: 1, Issue:6 Topics: Aged; Aged, 80 and over; Clinical Trials as Topic; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pravastatin; Research Design; Vascular Diseases	2004
Pravastatin enhances beneficial effects of olmesartan on vascular injury of salt-sensitive hypertensive rats, via pleiotropic effects. Arteriosclerosis, thrombosis, and vascular biology, 2007, Volume: 27, Issue:3 Topics: Animals; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Endothelium, Vascular; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Imidazoles; Nitric Oxide; Oxidation-Reduction; Oxidative Stress; Pravastatin; Rats; Rats, Inbred Dahl; Reference Values; Risk Factors; Sensitivity and Specificity; Sodium Chloride, Dietary; Tetrazoles; Vascular Diseases	2007
[Effect of cholestyramine on angiopathies in cholesterol-fed mice and diabetic mice]. Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi, 1995, Volume: 31, Issue:6 Topics: Animals; Anticholesteremic Agents; Cholesterol, Dietary; Cholestyramine Resin; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Hypercholesterolemia; Male; Mice; Mice, Inbred ICR; Pravastatin; Vascular Diseases; Vasodilation	1995